Galderma
- In 2010, Galderma reported sales of 1,203.5 million euros, an increase of 16.1% over 2009 at comparable exchange rates.
- More than 3 200 people work for Galderma throughout the world.
- Our products are distributed in over 70 countries.
- Approximately 20% revenues are invested annually to discover and develop new drugs and access innovative technologies.
- Galderma’s research efforts have allowed the company to issue 1 700 scientific publications, develop more than 550 inventions and file 5 500 patent applications and patents.
- 3 R&D centers (France, United States and Japan).
- 3 manufacturing sites (France, Canada and Brazil).
- 31 affiliates in the major countries of the globe’s five continents.
- Founded in 1981 as a joint venture between Nestlé and L'Oréal.
Sort by
Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.
| | |